Janux Therapeutics (JANX) CEO David Alan Campbell Gifts 123,840 Shares

What Happened

• David Alan Campbell, President, CEO and Director of Janux Therapeutics (NASDAQ: JANX), reported a gift disposition of 123,840 shares on July 31, 2026. The transaction is coded as a gift (G) and shows a price of $0.00, so no cash proceeds were received.

Key Details

• Transaction date: 2026-07-31
• Transaction type: Gift (Form 4 code G); reported as "Disposed" — 123,840 shares
• Price per share: $0.00; total cash received: $0
• Shares owned after the transaction: Not disclosed in the information provided
• Filing timing: Form 4 was filed with the SEC on 2026-07-31 (same date as the transaction)
• Footnotes/plan notes: None provided in the supplied data

Context

• Gifts are transfers of ownership (to family members, trusts, or charities) and do not necessarily reflect the insider's view of the company's prospects. They differ from open-market sales and purchases and often have tax, estate-planning, or personal reasons behind them.